Johannes Kornhuber
Johannes Kornhuber
Professor for Psychiatry, University of Erlangen
Verified email at uk-erlangen.de - Homepage
Title
Cited by
Cited by
Year
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease
D Harold, R Abraham, P Hollingworth, R Sims, A Gerrish, ML Hamshere, ...
Nature genetics 41 (10), 1088-1093, 2009
26212009
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease
P Hollingworth, D Harold, R Sims, A Gerrish, JC Lambert, ...
Nature genetics 43 (5), 429-435, 2011
16062011
Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis
WJ Jansen, R Ossenkoppele, DL Knol, BM Tijms, P Scheltens, ...
Jama 313 (19), 1924-1938, 2015
8502015
Analysis of shared heritability in common disorders of the brain
V Anttila, B Bulik-Sullivan, HK Finucane, RK Walters, J Bras, L Duncan, ...
Science 360 (6395), 2018
6102018
Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing
BW Kunkle, B Grenier-Boley, R Sims, JC Bis, V Damotte, AC Naj, ...
Nature genetics 51 (3), 414-430, 2019
5402019
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease
R Sims, SJ Van Der Lee, AC Naj, C Bellenguez, N Badarinarayan, ...
Nature genetics 49 (9), 1373-1384, 2017
4292017
Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt–Jakob disease
M Otto, J Wiltfang, H Tumani, I Zerr, M Lantsch, J Kornhuber, T Weber, ...
Neuroscience letters 225 (3), 210-212, 1997
4031997
Therapeutic approaches to Alzheimer's disease
HW Klafki, M Staufenbiel, J Kornhuber, J Wiltfang
Brain 129 (11), 2840-2855, 2006
4002006
Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents—preclinical studies
W Danysz, CG Parsons, J Kornhuber, WJ Schmidt, G Quack
Neuroscience & Biobehavioral Reviews 21 (4), 455-468, 1997
3941997
Effects of the 1-amino-adamantanes at the MK-801-binding site of the NMDA-receptor-gated ion channel: a human postmortem brain study
J Kornhuber, J Bormann, M Hübers, K Rusche, P Riederer
European Journal of Pharmacology: Molecular Pharmacology 206 (4), 297-300, 1991
3461991
Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease
L Jones, PA Holmans, ML Hamshere, D Harold, V Moskvina, D Ivanov, ...
PloS one 5 (11), e13950, 2010
3302010
Highly conserved and disease‐specific patterns of carboxyterminally truncated Aβ peptides 1–37/38/39 in addition to 1–40/42 in Alzheimer's disease and in patients with chronic …
J Wiltfang, H Esselmann, M Bibl, A Smirnov, M Otto, S Paul, B Schmidt, ...
Journal of neurochemistry 81 (3), 481-496, 2002
3052002
Neurochemical diagnosis of Alzheimer’s dementia by CSF Aβ42, Aβ42/Aβ40 ratio and total tau
P Lewczuk, H Esselmann, M Otto, JM Maler, AW Henkel, MK Henkel, ...
Neurobiology of aging 25 (3), 273-281, 2004
3012004
Memantine displaces [3H] MK-801 at therapeutic concentrations in postmortem human frontal cortex
J Kornhuber, J Bormann, W Retz, M Hübers, P Riederer
European journal of pharmacology 166 (3), 589-590, 1989
2901989
Psychotogenicity and N-methyl-D-aspartate receptor antagonism: implications for neuroprotective pharmacotherapy
J Kornhuber, M Weller
Biological psychiatry 41 (2), 135-144, 1997
2891997
(3H]MK-801 binding sites in postmortem brain regions of schizophrenic patients
J Kornhuber, F Mack-Burkhardt, P Riederer, GF Hebenstreit, GP Reynolds, ...
Journal of Neural Transmission 77 (2-3), 231-236, 1989
2621989
BOLD fMRI deactivation of limbic and temporal brain structures and mood enhancing effect by transcutaneous vagus nerve stimulation
T Kraus, K Hösl, O Kiess, A Schanze, J Kornhuber, C Forster
Journal of neural transmission 114 (11), 1485-1493, 2007
2612007
Acid sphingomyelinase–ceramide system mediates effects of antidepressant drugs
E Gulbins, M Palmada, M Reichel, A Lüth, C Böhmer, D Amato, CP Müller, ...
Nature medicine 19 (7), 934-938, 2013
2592013
Functional Inhibitors of Acid Sphingomyelinase (FIASMAs): a novel pharmacological group of drugs with broad clinical applications
J Kornhuber, P Tripal, M Reichel, C Mühle, C Rhein, M Muehlbacher, ...
Cellular Physiology and Biochemistry 26 (1), 9-20, 2010
2492010
Analysis of shared heritability in common disorders of the brain
Brainstorm Consortium
Science (New York, NY) 360 (6395), 2018
2462018
The system can't perform the operation now. Try again later.
Articles 1–20